genetic screening

Oncology

Functional cancer profiling is an important step forward in the progress of oncology treatment, with the potential to transform patient outcomes.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.